Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07223255 · ClinicalTrials.gov registry record · NA

Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet

A NA study, sponsored by Dartmouth-Hitchcock Medical Center.

Recruiting
Registry status
NA
Development phase
20
Enrollment target

NCT07223255 is a NA study that is actively recruiting participants, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 20 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07223255, a NA study, is actively recruiting participants, sponsored by Dartmouth-Hitchcock Medical Center.

RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

There is no study to date that has evaluated the impact or effect of a Mediterranean diet in children with CF. The goal of this study would be to help provide better guidance around questions the investigators, as CF care providers continue to receive from patients and families about how to best promote overall health in pediatric cystic fibrosis from a dietary perspective. Currently, the updated nutritional recommendations are variable and broad. Parents continue to search for more concrete guidance about how best to promote long-term health given the ever-increasing life expectancy of cystic fibrosis patients in this new area of advanced therapeutics. Given the changing landscape of the CF care in general, children are less likely to struggle with early life malnutrition, and it is becoming increasingly clear that high fat, high calorie diets are not beneficial nor are necessary for all children with CF.

Interventions

  • OTHER Mediterranean diet

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-09-01
Est. Completion 2027-06
Phase NA

Sponsor

Dartmouth-Hitchcock Medical Center

427 total trials

What the Registry Record Tells You About NCT07223255

The ClinicalTrials.gov registry entry for NCT07223255 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Mediterranean diet is the first listed.

NCT07223255 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07223255 about?

NCT07223255 is a clinical study titled "Gastrointestinal Response of Pediatric Cystic Fibrosis Patients on Mediterranean Diet". There is no study to date that has evaluated the impact or effect of a Mediterranean diet in children with CF. The goal of this study would be to help provide better guidance around questions the investigators, as CF care providers continue to receive from patients and families about how to best pro...

What is the current status of trial NCT07223255?

This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-09-01. Estimated completion is 2027-06.

What interventions are being tested in trial NCT07223255?

The interventions under investigation include: Mediterranean diet (OTHER).

Who is sponsoring clinical trial NCT07223255?

This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.